A Step-By-Step Surgical Protocol for the Treatment of Perianal Fistula with Adipose-Derived Mesenchymal Stem Cells

Referencias bibliográficas

• Ritchie RD, Sackier JM, Hodde JP. Incontinence rates after cutting seton treatment for anal fistula. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2009;11(6):564–71. doi: https://doi.org/10.1111/j.1463-1318.2008.01713.x .
• Balciscueta Z, Uribe N, Balciscueta I, Andreu-Ballester JC, Garcia-Granero E. Rectal advancement flap for the treatment of complex cryptoglandular anal fistulas: a systematic review and meta-analysis. International journal of colorectal disease. 2017;32(5):599–609. doi: https://doi.org/10.1007/s00384-017-2779-7 .
• Trebol Lopez J, Georgiev Hristov T, Garcia-Arranz M, Garcia-Olmo D. Stem cell therapy for digestive tract diseases: current state and future perspectives. Stem cells and development. 2011;20(7):1113–29. doi: https://doi.org/10.1089/scd.2010.0277 .
• Panes J, Garcia-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet (London, England). 2016;388(10051):1281–90. doi: https://doi.org/10.1016/s0140-6736(16)31203-x .
• Herreros MD, Garcia-Arranz M, Guadalajara H, De-La-Quintana P, Garcia-Olmo D. Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation. Diseases of the colon and rectum. 2012;55(7):762–72. doi: https://doi.org/10.1097/DCR.0b013e318255364a .
• Wang S, Guo L, Ge J, Yu L, Cai T, Tian R et al. Excess Integrins Cause Lung Entrapment of Mesenchymal Stem Cells. Stem cells (Dayton, Ohio). 2015;33(11):3315–26. doi: https://doi.org/10.1002/stem.2087 .
• Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Diseases of the colon and rectum. 2005;48(7):1416–23. doi: https://doi.org/10.1007/s10350-005-0052-6 .
• Garcia-Olmo D, Garcia-Arranz M, Garcia LG, Cuellar ES, Blanco IF, Prianes LA et al. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. International journal of colorectal disease. 2003;18(5):451–4. doi: https://doi.org/10.1007/s00384-003-0490-3 .
• Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PloS one. 2012;7(10):e47559. doi: https://doi.org/10.1371/journal.pone.0047559 .
• Garcia-Olmo D, Herreros D, Pascual M, Pascual I, De-La-Quintana P, Trebol J et al. Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. International journal of colorectal disease. 2009;24(1):27–30. doi: https://doi.org/10.1007/s00384-008-0559-0 .
• Pountos I, Georgouli T, Henshaw K, Howard B, Giannoudis PV. Mesenchymal Stem Cell physiology can be affected by antibiotics: An in vitro study. Cellular and molecular biology (Noisy-le-Grand, France). 2014;60(4):1–7.
• Chang Y, Goldberg VM, Caplan AI. Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells. Clinical orthopaedics and related research. 2006;452:242–9. doi: https://doi.org/10.1097/01.blo.0000229324.75911.c7 .
• Sung PH, Chiang HJ, Chen CH, Chen YL, Huang TH, Zhen YY et al. Combined Therapy With Adipose-Derived Mesenchymal Stem Cells and Ciprofloxacin Against Acute Urogenital Organ Damage in Rat Sepsis Syndrome Induced by Intrapelvic Injection of Cecal Bacteria. Stem cells translational medicine. 2016;5(6):782–92. doi: https://doi.org/10.5966/sctm.2015-0116 .
• Sisto F, Bonomi A, Cavicchini L, Cocce V, Scaltrito MM, Bondiolotti G et al. Human mesenchymal stromal cells can uptake and release ciprofloxacin, acquiring in vitro anti-bacterial activity. Cytotherapy. 2014;16(2):181–90. doi: https://doi.org/10.1016/j.jcyt.2013.11.009 .
• Dregalla RC, Lyons NF, Reischling PD, Centeno CJ. Amide-type local anesthetics and human mesenchymal stem cells: clinical implications for stem cell therapy. Stem cells translational medicine. 2014;3(3):365–74. doi: https://doi.org/10.5966/sctm.2013-0058 .
• Gray A, Marrero-Berrios I, Weinberg J, Manchikalapati D, SchianodiCola J, Schloss RS et al. The effect of local anesthetic on pro-inflammatory macrophage modulation by mesenchymal stromal cells. International immunopharmacology. 2016;33:48–54. doi: https://doi.org/10.1016/j.intimp.2016.01.019 .
• Muller G, Kramer A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. The Journal of antimicrobial chemotherapy. 2008;61(6):1281–7. doi: https://doi.org/10.1093/jac/dkn125 .
• Thomas GW, Rael LT, Bar-Or R, Shimonkevitz R, Mains CW, Slone DS et al. Mechanisms of delayed wound healing by commonly used antiseptics. The Journal of Trauma. 2009;66(1):82–90; discussion −1. doi: https://doi.org/10.1097/TA.0b013e31818b146d .
• Mamidi MK, Singh G, Husin JM, Nathan KG, Sasidharan G, Zakaria Z et al. Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications. Journal of translational medicine. 2012;10:229. doi: https://doi.org/10.1186/1479-5876-10-229 .
• Baars JE, Kuipers EJ, Dijkstra G, Hommes DW, de Jong DJ, Stokkers PC et al. Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands. Scandinavian Journal of Gastroenterology. 2011;46(3):319–25. doi: https://doi.org/10.3109/00365521.2010.536251 .
• Chang AI, Schwertschkow AH, Nolta JA, Wu J. Involvement of mesenchymal stem cells in cancer progression and metastases. Current cancer drug targets. 2015;15(2):88–98.
• Hong IS, Lee HY, Kang KS. Mesenchymal stem cells and cancer: friends or enemies? Mutation research. 2014;768:98–106. doi: https://doi.org/10.1016/j.mrfmmm.2014.01.006 .
• Duijvestein M, Molendijk I, Roelofs H, Vos AC, Verhaar AP, Reinders ME et al. Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy 2011;13(9):1066–73. doi: https://doi.org/10.3109/14653249.2011.597379 .
• Schneider N, Goncalves Fda C, Pinto FO, Lopez PL, Araujo AB, Pfaffenseller B et al. Dexamethasone and azathioprine promote cytoskeletal changes and affect mesenchymal stem cell migratory behavior. PloS one. 2015;10(3):e0120538. doi: https://doi.org/10.1371/journal.pone.0120538 .
• Qiu Y, Li MY, Feng T, Feng R, Mao R, Chen BL et al. Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's disease. Stem cell research & therapy. 2017;8(1):136. doi: https://doi.org/10.1186/s13287-017-0570-x .
• Lightner AL, Wang Z, Zubair AC, Dozois EJ. A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn's Disease: Progress Made and Future Directions. Diseases of the colon and rectum. 2018;61(5):629–40. doi: https://doi.org/10.1097/dcr.0000000000001093 .
• Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Diseases of the colon and rectum. 2009;52(1):79–86. doi: https://doi.org/10.1007/DCR.0b013e3181973487 .